
Resources
Home
/
Resources
-
Microbial Challenge In-use Studies - Industry efforts to harmonize strategies in collaboration with Health Authorities
Speaker Presentation Leiske Seagen Inc. Zamiri Genentech 2022
-
Use of Stability Modeling to Support Accelerated Biologicals and Vaccines Development and Real-Time Stability Supply
Speaker Presentation Clénet Didier Sanofi Pasteur 2022
-
Regulator Review Preferences and Recent Review Trends - Questions, Key Issues - 2
Roundtable 40 Notes: WCBP 2022
-
Method Selection and Acceptance Criteria to Support In-Use Stability and Compatibility Studies - 2
Roundtable 37 Notes: WCBP 2022
-
mRNA - Vaccines and Beyond
Roundtable 34 Notes: WCBP 2022
-
Acceleration and CMC - Novel Approaches to Enabling Acceleration
Roundtable 31 Notes: WCBP 2022
-
Strategies for Setting Phase Appropriate Endotoxin Specifications
Roundtable 29 Notes: WCBP 2022
-
New Advances and Applications in Real Time Release Testing
Roundtable 27 Notes: WCBP 2022
-
Nitrosamine Risk Assessments – Implementation
Roundtable 26 Notes: WCBP 2022
-
To Outsource (That Test) or Not to Outsource – That Is the Question! (Analytical Testing)
Roundtable 24 Notes: WCBP 2022
-
Modernizing Stability ICH Guidance, Including Science and Risk-Based Approaches to Encompass Biologics and New Modalities
Roundtable 23 Notes: WCBP 2022
-
Big Data Applications in Biopharmaceutical Process and Product Development
Roundtable 22 Notes: WCBP 2022
-
Setting Specifications on Limited Data, Clinically Relevant Specs
Roundtable 21 Notes: WCBP 2022
-
Considerations for Introducing Novel Excipients in DP Formulations, Across All Modalities
Roundtable 20 Notes: WCBP 2022
-
Regulator Review Preferences and Recent Review Trends - Questions, Key Issues
Roundtable 18 Notes: WCBP 2022
-
Opportunities for Engagement and Collaboration to Achieve Stakeholder Alignment on Closed System Transfer Devices (CSTDs)
Roundtable 17 Notes: WCBP 2022
-
Intra-Site and Inter-Site Transfer of Analytical Methods for the Biopharmaceutical Products - Approach and Namely Regulatory Experiences
Roundtable 16 Notes: WCBP 2022
-
Method Selection and Acceptance Criteria to Support In-Use Stability and Compatibility Studies
Roundtable 15 Notes: WCBP 2022
-
Academic Connections and Collaborations to Accelerate Drug Development
Roundtable 14 Notes: WCBP 2022
-
Global Filings, In-Country Testing Challenges and Solutions
Roundtable 12 Notes: WCBP 2022